Study of radiotherapy resistance associated to EGFR/MAPK signaling pathway and its application in the rational design of a treatment with simvastatin in combination with cetuximab and radiotherapy (in experimental models of carcinoma)

Aqui va el pdf

Documents amb el text complet d'aquesta tesi

Aquesta tesi apareix a les col·leccions següents